Skip to main content
Premium Trial:

Request an Annual Quote

Hutch, Partners File Infringement Suit Against MMI Genomics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center, along with other plaintiffs, have filed a patent infringement suit against MMI Genomics alleging infringement of a patent covering canine genetics.

The suit, which was recently filed in the US District Court for the Eastern District of Virginia, claims that Davis, Calif.-based MMI Genomics is infringing US Patent No. 7,729,863, a patent covering canine breed identification methods. The patent is assigned to the Hutch and was exclusively licensed to Argus Genetics and exclusively sublicensed to Mars, Inc. — both of which are listed as plaintiffs in the case.

According to the suit, MMI has directly infringed, and is inducing infringement of, one or more claims of the '863 patent through the sale of its Canine Heritage XL Breed Test product and associated services. The plaintiffs claim they have been damaged monetarily by the infringement, and MMI is liable for such damages, "and in no event less than a reasonable royalty."

The plaintiffs also seek a judgment that MMI has infringed the patent, an order to stop MMI from further infringement, damages, and pre- and post-judgment interest and costs.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.